Ergosterol
PreliminaryMechanism of Action
Research Notes
In vivo studies in Lewis lung carcinoma models demonstrated significant reduction of pulmonary metastatic nodule formation following oral ergosterol supplementation. Anti-angiogenic activity was confirmed in subcutaneous tumor implant models where ergosterol reduced microvessel density surrounding tumors. No direct in vitro cytotoxicity was observed, confirming the anti-angiogenic rather than cytotoxic mechanism.
Found In 1 Herb
3D Molecular Structure
Ergosterol
Representative pattern: C₂₁H₃₀O₂
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.
